Higher kynurenine concentrations have been reported in prostatic tumoral tissues and in serum samples of PCa cases compared to controls and are associated with a more aggressive disease [61–64] in keeping with an increased risk of progression for PCa individuals with germline UGT2B17 KO. The gene discussed is UGT2B17; the disease is posterior cortical atrophy.